Methoxyphenamine

This classification denotes a beta-adrenergic agonist with the molecular formula C11H17NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J3Z5SRI26Z, chemically known as 2-methoxy-n,alpha-dimethylphenethylamin but generally known as methoxyphenamine, which bears US NIH Compound Identifier 4117. European Medicines Agency schedules Methoxyphenamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08860MIG. The term METHOXYPHENAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules methoxyphenamine in its Anatomical Therapeutic Chemical (ATC) Classification. METHOXYPHENAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methoxyphenamine under HS 29222900 and SITC 51462. As of Q4 2014, METHOXYPHENAMINE remains the US FDA Preferred Term for this commodity. Methoxyphenamine bears US NLM identifiers UMLS ID C0066165 and NCI Concept Code C83958. SMILES: CC(CC1=CC=CC=C1OC)NC.